Valuation: Crossject

Market Cap 97.35M 111M 89.39M 83.36M 158M 10.61B 161M 1.08B 417M 5.2B 418M 409M 17.92B P/E 2026 *
4.36x
P/E 2027 * 3.44x
Enterprise Value 79.45M 90.92M 72.95M 68.03M 129M 8.66B 131M 878M 340M 4.25B 341M 334M 14.63B EV / Sales 2026 *
1.31x
EV / Sales 2027 * 1.19x
Free-Float
89.86%
Yield 2026 *
-
Yield 2027 * -
1 day+0.67%
1 week-1.75%
Current month+0.90%
1 month-8.72%
3 months-10.22%
6 months-24.53%
Current year-17.81%
1 week 1.76
Extreme 1.764
1.87
1 month 1.76
Extreme 1.764
2.03
Current year 1.76
Extreme 1.764
2.58
1 year 1.35
Extreme 1.346
2.7
3 years 0.72
Extreme 0.7199
5.96
5 years 0.72
Extreme 0.7199
5.96
10 years 0.72
Extreme 0.7199
8.36
Manager TitleAgeSince
Chief Executive Officer 63 07/08/2001
Director of Finance/CFO - 24/03/2026
Corporate Officer/Principal - 19/08/2024
Director TitleAgeSince
Chairman 67 25/06/2009
Director/Board Member 67 -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
03/07/25Buy

Director

13,386 0.0266%
30/06/25Buy

Director

337 0.0007%
30/06/25Buy

Director

50 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+0.67%-1.75%+13.49%-54.49% 111M
+0.52%+4.76%-28.96%-68.52% 89.15M
-0.14%-2.19%+61.99%+5.60% 68.57M
Average +0.18%+0.78%+15.51%-39.13% 89.71M
Weighted average by Cap. +0.24%+0.63%+11.79%-43.82%

Financials

2026 *2027 *
Net sales 60.8M 69.58M 55.83M 52.07M 98.71M 6.62B 100M 672M 261M 3.25B 261M 256M 11.2B 42.3M 48.41M 38.84M 36.22M 68.67M 4.61B 69.83M 468M 181M 2.26B 182M 178M 7.79B
Net income 28.3M 32.39M 25.99M 24.23M 45.94M 3.08B 46.72M 313M 121M 1.51B 122M 119M 5.21B 7.75M 8.87M 7.12M 6.64M 12.58M 844M 12.79M 85.69M 33.21M 414M 33.3M 32.58M 1.43B
Net Debt -17.9M -20.49M -16.44M -15.33M -29.06M -1.95B -29.55M -198M -76.7M -957M -76.92M -75.25M -3.3B -47M -53.79M -43.16M -40.25M -76.3M -5.12B -77.59M -520M -201M -2.51B -202M -198M -8.65B
Logo Crossject
Crossject specializes in manufacturing and marketing needleless drug self-injection. The group provides Zeneo, a prefilled and single-use device that can be used for intradermal, subcutaneous and intramuscular injections.
Employees
99
Date Price Change Volume
03/07/26 1.800 +0.67% 60,141
02/07/26 €1.788 -0.45% 88,832
01/07/26 €1.796 +0.67% 203,636
30/06/26 €1.784 -3.25% 272,088
29/06/26 €1.844 +0.66% 98,488
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.788EUR
Average target price
4.400EUR
Spread / Average Target
+146.09%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ALCJ Stock